官方服务：
资源简介：
Target identification project for Harzianin, a peptaibol with antimalarial activity.
应用场景：
创建时间：
2022-03-04
相关数据集
Therapy resistant primitive stem cells in chronic myelogenous leukemia are characterized by low c-Kit expression and altered SCF response
Leukemia stem cells (LSC) in chronic myelogenous leukemia (CML) resist elimination with tyrosine kinase inhibitors (TKI) and persist as a source of disease recurrence. LSC populations are heterogeneou
NIAID Data Ecosystem50
Protein expression in TKI-resistant RCC cells.
Resistance to tyrosine kinase inhibitors is an essential issue concerning targeted therapy in renal cancer. This research focuses on molecular background of resistance to axitinib and sorafenib observ
NIAID Data Ecosystem30
sj-xlsx-1-tam-10.1177_17588359221079125 – Supplemental material for Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models
Supplemental material, sj-xlsx-1-tam-10.1177_17588359221079125 for Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models by Sun Min Lim, San-Duk Yang, Sangbi
DataCite Commons2024-08-28 更新20
Comprehensive evaluation of MEK inhibitors for malignant peripheral nerve sheath tumors reveals differences in efficacy and drug resistance development. Comprehensive evaluation of MEK inhibitors for malignant peripheral nerve sheath tumors reveals differences in efficacy and drug resistance development
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft-tissue sarcomas which lack effective drugs. Previous studies support the usefulness of MEK inhibitors (MEKis) for treating RAS-dri
NIAID Data Ecosystem30
